CN Patent
CN113214334A — 用于治疗病毒感染的化合物及其制备方法和用途
Assigned to Huachuang Synthetic Pharmaceutical Co Ltd · Expires 2021-08-06 · 5y expired
What this patent protects
本文提供了用于治疗病毒感染的肺病毒亚科病毒感染的制剂、方法和式(Ⅰ)的化合物以及用于合成式(Ⅰ)化合物的方法和中间体。
USPTO Abstract
本文提供了用于治疗病毒感染的肺病毒亚科病毒感染的制剂、方法和式(Ⅰ)的化合物以及用于合成式(Ⅰ)化合物的方法和中间体。
Drugs covered by this patent
- Veklury (remdesivir) · Gilead Sciences
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.